Successful engraftment in crossmatch-positive HLA-mismatched peripheral blood stem cell transplantation after depletion of antidonor cytotoxic HLA antibodies with rituximab and donor platelet infusion.
Narimatsu
H
H
Wake
A
A
Miura
Y
Y
Tanaka
H
H
Matsumura
T
T
Takagi
S
S
Kato
D
D
Myojo
T
T
Kusumi
E
E
Masuoka
K
K
Miyakoshi
S
S
Morinaga
S
S
Saji
H
H
Ichinohe
T
T
Taniguchi
S
S
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006085:Graft Survival; D006680:HLA Antigens / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D007518:Isoantibodies / Q000187:drug effects*; D036102:Peripheral Blood Stem Cell Transplantation / Q000379:methods*; D017713:Platelet Transfusion; D000069283:Rituximab; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D006680:HLA Antigens; D007518:Isoantibodies; D000069283:Rituximab